Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9492384 | ALMIRALL | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
US8962000 | ALMIRALL | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
US8460641 | ALMIRALL | Microemulsion process and composition |
Aug, 2027
(4 years from now) |
Market Authorisation Date: 19 September, 2006
Treatment: Treatment of atopic dermatitis
Dosage: AEROSOL, FOAM;TOPICAL
6
United States
2
Australia
2
Canada
2
European Union
1
Taiwan, Province of China
1
Korea, Republic of
1
Japan
1
Hong Kong
1
Israel
1
Poland
1
Russia
1
Argentina
1
South Africa
1
Spain
1
China
1
Brazil
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic